Ion-Pair ReversedPhase Analysis of an Oligonucleotide Ladder Standard with Avantor® ACE® Oligo
contributed by Avantor |
Oligonucleotides are short lengths of DNA/RNA which are increasingly being used as therapeutic agents for the treatment of genetic disorders and cancers.
With oligonucleotide treatments, it is possible to synthesize a single-strand of DNA/RNA which has a complementary sequence to a disease-causing gene. Once this therapeutic DNA sequence has bound to the target gene in the body, the gene is deactivated. This method of treatment is known as antisense therapy
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.